Andreas Kakouris

This inventor holds 10 USPTO granted patents and 10 published patent applications and 15 EPO patents. Top assignees: Pharmathen S.a., Ntc S.r.l.. Active years: 2019-2026.

USPTO Granted Patents = 10 (Patent Applications = 10)

% Patents Active = 100.0

EPO Patents = 15 (Patent Applications = 25)

Average Co-Inventor Count = 8.6

ph-index = 1

Company Filing History:

Years Active: 2019-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582603 - Ophthalmic pharmaceutical composition containing a combination of brinzolamide and brimonidine and method of preparation thereof (2026-03-24),

2. 12458645 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2025-11-04),

3. 12453732 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2025-10-28),

4. 11969429 - Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof (2024-04-30),

5. 11318114 - Water dispersible mini-tablets comprising Enalapril for treatment of hypertension in a pediatric population and method of preparation thereof (2022-05-03),

6. 11229596 - Preservative free pharmaceutical ophthalmic compositions (2022-01-25),

7. 11154585 - Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population (2021-10-26),

8. 10772830 - Preservative free pharmaceutical compositions for ophthalmic administration (2020-09-15),

9. 10702471 - Preservative free pharmaceutical compositions for ophthalmic administration (2020-07-07),

10. 10350161 - Preservative free pharmaceutical compositions for ophthalmic administration (2019-07-16),

Title: Innovations by Andreas Kakouris

Introduction

Andreas Kakouris is a notable inventor based in Pallini Attikis, Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. With a total of nine patents to his name, Kakouris has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

One of his latest patents is titled "Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof." This invention involves a powder that includes Valaciclovir or a pharmaceutical acceptable salt or derivative thereof, combined with an ion exchange resin. The Valaciclovir is complexed with the ion exchange resin to form Drug-Resin complex (DRC) particles. Each DRC particle comprises hydrogen bonds between the ion exchange resin and a cationic center of Valaciclovir. The ratio of Valaciclovir to the ion exchange resin in the DRC particle is 1:0.5. Additionally, the powder includes a suspending agent and a pH agent, with the suspending agent forming a film around each DRC particle to decrease interparticle attraction. This powder is designed to be reconstituted with an aqueous diluent for oral administration.

Career Highlights

Kakouris has been instrumental in the pharmaceutical industry, particularly through his work at Pharmathen S.A. His innovative approaches have led to advancements in drug formulation and delivery systems. His expertise in complexing agents with ion exchange resins has opened new avenues for pediatric medication.

Collaborations

Andreas Kakouris has collaborated with notable colleagues, including Evangelos Karavas and Vasiliki Samara. Their combined efforts have contributed to the successful development of various pharmaceutical innovations.

Conclusion

Andreas Kakouris is a prominent inventor whose work in the pharmaceutical field has led to significant advancements in antiviral treatments. His innovative patents reflect his dedication to improving healthcare solutions for pediatric patients.